Oxford Immunotec Global - M&A Summary, Ownership, and Business Overview

Medical ProductsCompany

Oxford Immunotec Global M&A Summary

Oxford Immunotec Global has acquired 3 companies of its own.

Oxford Immunotec Global’s largest acquisition to date was in 2016, when it acquired Imugen for $22M. Oxford Immunotec Global has acquired in 2 different US states. The Company’s most targeted sectors include test/measurement equipment (34%) and life science (34%).

Oxford Immunotec Global Ownership

Who owns Oxford Immunotec Global?

Oxford Immunotec Global is owned by Revvity. It was acquired on January 7, 2021.

Oxford Immunotec Global Business Overview

Where is Oxford Immunotec Global headquartered?

Oxford Immunotec Global is headquartered in Abingdon, United Kingdom.

What is Oxford Immunotec Global’s revenue?

Oxford Immunotec Global disclosed revenue of 74M USD for 2019 and 60M USD for 2018.

How many employees does Oxford Immunotec Global have?

Oxford Immunotec Global has 260 employees.

What sector is Oxford Immunotec Global in?

Oxford Immunotec Global is a medical products company.

When was Oxford Immunotec Global founded?

Oxford Immunotec Global was founded in 2002.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 3
  • Total Countries Invested 1

Oxford Immunotec Global PLC

143 Park Drive Milton Park,
Abingdon, OX14 4SE
United Kingdom,
+44 1235 442780
www.oxfordimmunotec.com

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. The Company’s first product is the T-SPOT.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The T-SPOT.CMV test and the T-SPOT.PRT test are the Company’s second and third products and part of a series of products intended for the transplantation market. In addition to these three products, the Company has an additional six active development programs, each of which leverages our T cell, B cell and innate immune measuring technology. Oxford Immunotec Global was founded in 2002 and is based in Abingdon, the United Kingdom.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $36M $36M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Immunetics, Inc. 2016-10-12 6M USD Add-on Acquisition
Boston, Massachusetts · www.immunetics.com
Imugen, Inc. 2016-06-23 22M USD Add-on Acquisition
Norwood, Massachusetts · www.imugen.com
Boulder Diagnostics, Inc. 2014-08-05 8M USD Add-on Acquisition
Boulder, Colorado · www.oxfordimmunotec.com/north-america/boulder-diagnostics
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (33%) 6M (17%) - -
Medical Products 1 (33%) 8M (22%) - -
Test/Measurement Equipment 1 (33%) 22M (61%) - -
Total 3 $36M - -

By Geo

State/Country Buy Value Sell Value
United States 3 36M - -
  Massachusetts 2 28M - -
  Colorado 1 8M - -
Total 3 $36M - -

Deal Values

buy # Total
< $100M 3 $36M
TOTAL $36M
Largest Imugen, Inc.
$22M (2016-06-23)

 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Oxford Immunotec Global

Medical Products Companies , United Kingdom Companies